Caption Management’s iTeos Therapeutics ITOS Stock Holding History

Caption Management’s Portfolio ITOS Stock Details ITOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-22,157	Closed	-$221K	–	1848
2025 Q2	$221K	Sell	22,157 -132,336	-86%	-$1.07M	﹤0.01%	1248
2025 Q1	$922K	Sell	154,493 -355,336	-70%	-$2.61M	0.01%	947
2024 Q4	$3.92M	Buy	+509,829	New	+$4.38M	0.04%	453
2024 Q3	–	Sell	-19,000	Closed	-$290K	–	1450
2024 Q2	$282K	Buy	+19,000	New	+$272K	﹤0.01%	908
2022 Q3	–	Sell	-25,600	Closed	-$527K	–	1672
2022 Q2	$527K	Buy	25,600 +7,600	+42%	+$180K	0.01%	1065
2022 Q1	$579K	Buy	+18,000	New	+$654K	0.01%	1111

Other funds holding ITOS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Caption Management's ITOS Position: Q3 2025 in Review

Caption Management sold out of iTeos Therapeutics (ITOS) in Q3 2025, closing a stake of 22,157 shares — an estimated $221K sold.

Caption Management first reported a position in ITOS in Q1 2022 and held it in 6 quarters. The position peaked at $3.92M in Q4 2024. 1 fund tracked by Wall St. Rank holds ITOS as of Q3 2025.

Caption Management reported no remaining iTeos Therapeutics position as of Q3 2025 after selling out during the quarter.
Caption Management sold 22,157 iTeos Therapeutics shares in Q3 2025, an estimated $221K.
Caption Management first reported a position in iTeos Therapeutics in Q1 2022 and held it in 6 quarters.
Caption Management's iTeos Therapeutics position peaked at $3.92M in Q4 2024.
1 fund tracked by Wall St. Rank held iTeos Therapeutics as of Q3 2025.

Based on Caption Management's 13F filing for Q3 2025, filed 14 Nov 2025.